YOLFTbeta
00

Huapont Life Sciences Co Ltd

002004 · SHE · Basic Materials / Agricultural Inputs

4.56CNY+0.03 (+0.66%)

Price History

Full chart

Market Stats

Previous Close4.53
Open4.53
Day Range4.51 – 4.63
52-Week Range3.79 – 5.63
Volume22.35M
Market Cap8.55B
P/E (TTM)13.09
Forward P/E20.79
EPS0.33
Dividend Yield8.22%
Beta0.26
50-Day Avg4.44
200-Day Avg4.84

About

Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management products. In addition, it provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Further, the company engages in the research and development, production, and sales of fine chemical products and polymer materials, as well as provides tourism services and agent for the promotion of preparation products. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co.,Ltd. in September 2015. Huapont Life Sciences Co.,Ltd. was founded in 1992 and is headquartered in Chongqing, China.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Hai An Zhang
  • Employees11.95K
  • Headquarters69 Renhe Xingguang Avenue, Chongqing, China, 401121, China
  • Websitehttps://www.huapont.com.cn

Leadership

  • Mr. Hai An ZhangGM & Director · b. 1981
  • Mr. Jian WangCFO & Accounting Supervisor · b. 1976
  • Ms. Jingjing HuBoard Secretary · b. 1984

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue174.05M200.22M240.44M272.53M273.50M287.87M492.37M565.84M544.52M541.22M628.90M3.88B4.47B4.87B6.17B7.09B9.18B10.57B10.09B10.88B12.43B13.23B11.59B11.66B11.51B
Growth (%)-+15.04%+20.09%+13.35%+0.36%+5.25%+71.04%+14.92%-3.77%-0.61%+16.20%+516.54%+15.16%+9.00%+26.87%+14.88%+29.47%+15.15%-4.56%+7.78%+14.29%+6.45%-12.38%+0.60%-1.31%
Cost of Revenue56.41M63.99M70.74M64.57M63.20M63.66M182.63M203.17M189.71M176.88M211.72M2.90B3.30B3.40B4.05B4.80B6.29B6.35B5.45B6.47B7.76B7.97B7.21B7.83B7.26B
Gross Profit117.64M136.24M169.70M207.96M210.31M221.57M309.74M372.56M354.81M364.34M426.37M978.26M1.16B1.47B2.12B2.29B2.89B4.23B4.64B4.41B4.67B5.26B4.39B3.84B4.25B
Gross Margin67.59%68.04%70.58%76.31%76.89%76.97%62.91%65.84%65.16%67.32%67.80%25.23%26.01%30.18%34.40%32.27%31.47%39.98%45.98%40.52%37.58%39.76%37.83%32.90%36.92%
Operating Expense81.48M92.06M122.34M149.03M149.97M147.86M230.96M288.63M254.68M259.24M313.31M579.25M776.24M987.52M1.37B1.64B2.18B3.14B3.48B3.21B3.34B3.62B3.46B3.97B2.74B
Operating Income36.16M44.18M47.36M58.93M60.33M73.70M78.78M83.93M100.13M105.10M113.07M399.01M385.11M481.42M752.76M650.59M706.17M1.09B1.16B1.19B1.33B1.64B926.51M-127.44M1.51B
Operating Margin20.78%22.07%19.70%21.62%22.06%25.60%16.00%14.83%18.39%19.42%17.98%10.29%8.63%9.89%12.19%9.17%7.69%10.27%11.46%10.99%10.73%12.43%7.99%-1.09%13.09%
EBITDA36.33M49.97M56.57M68.62M75.45M87.47M289.14M165.84M144.69M196.15M377.73M642.78M612.81M935.02M1.43B1.43B1.66B2.30B2.35B2.46B2.49B2.84B2.09B1.14B2.43B
EBITDA Margin20.87%24.96%23.53%25.18%27.59%30.38%58.72%29.31%26.57%36.24%60.06%16.58%13.72%19.21%23.16%20.17%18.08%21.76%23.34%22.60%20.00%21.48%18.06%9.74%21.10%
Net Income31.11M37.30M39.92M47.65M52.50M64.14M206.46M88.81M127.68M132.04M305.28M332.38M302.68M429.18M636.63M566.87M505.79M506.45M620.21M651.73M667.81M433.48M302.12M-298.99M713.19M
Net Income Margin17.87%18.63%16.60%17.48%19.20%22.28%41.93%15.70%23.45%24.40%48.54%8.57%6.78%8.82%10.31%7.99%5.51%4.79%6.15%5.99%5.37%3.28%2.61%-2.56%6.19%
R&D------4.28M--13.51M15.46M61.91M73.62M199.87M243.57M228.00M244.48M349.46M288.03M324.35M329.47M385.24M419.14M375.32M341.62M
R&D as % of Total Revenue------0.87%--2.50%2.46%1.60%1.65%4.11%3.94%3.21%2.66%3.31%2.85%2.98%2.65%2.91%3.61%3.22%2.97%
Interest Expense372.19K1.78M3.25M1.68M411.51K784.92K14.46M19.52M7.58M8.02M12.59M90.31M89.20M227.50M352.96M399.55M565.25M645.40M598.38M596.20M488.05M448.70M343.70M369.51M309.32M
Interest Expense % of Total Revenue0.21%0.89%1.35%0.62%0.15%0.27%2.94%3.45%1.39%1.48%2.00%2.33%2.00%4.67%5.72%5.63%6.16%6.10%5.93%5.48%3.93%3.39%2.96%3.17%2.69%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets133.41M207.09M225.73M481.04M477.85M765.08M1.09B1.14B1.14B1.36B4.19B5.92B7.65B13.57B19.71B24.23B29.09B26.55B26.64B28.23B30.04B30.02B30.73B29.45B29.03B
Total Liabilities45.93M104.91M79.99M79.39M37.17M242.18M357.78M325.26M245.68M322.58M1.60B2.97B3.64B7.84B9.30B13.52B15.79B13.80B13.39B14.09B14.22B13.47B14.14B13.98B12.05B
Total Equity87.48M100.66M144.58M378.36M430.86M450.67M669.68M753.04M837.99M975.49M2.39B2.68B3.80B5.58B9.52B9.65B9.49B9.06B9.34B9.63B10.11B10.19B10.11B9.34B10.22B
Cash23.05M36.68M33.42M236.52M125.65M98.37M160.46M184.15M165.41M146.67M657.39M765.09M1.17B2.77B5.97B6.03B7.71B4.35B3.37B4.12B4.39B4.19B3.78B3.29B2.86B
Total Debt18.00M68.00M45.00M22.00M-130.64M231.29M153.31M85.94M115.74M678.72M1.34B1.60B5.97B6.32B8.98B11.50B9.72B8.92B9.13B8.57B8.05B8.63B6.56B-
Net Debt-5.05M31.32M11.58M-214.52M-125.65M32.27M70.83M-30.83M-79.47M-30.93M21.33M575.29M438.91M3.20B353.49M2.95B3.80B5.38B5.56B5.01B4.18B3.86B4.84B3.27B2.32B

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-36.88M56.68M70.60M43.69M66.10M79.21M113.76M123.53M79.84M135.23M257.75M349.51M455.96M342.45M511.90M591.40M1.91B2.08B2.37B1.27B2.41B1.59B1.63B2.10B
Investing Cash Flow--65.69M-26.82M-6.89M-128.15M-101.74M-102.72M-59.60M-23.57M-187.45M78.67M-586.26M-1.03B-2.68B-656.57M-3.03B342.54M-1.03B-1.36B-1.76B-790.43M-556.49M-1.75B-1.15B-
Financing Cash Flow-42.44M-33.13M139.39M-26.41M8.34M84.28M-44.08M-110.47M72.05M165.68M243.28M1.18B2.31B3.07B1.84B1.03B-3.21B-1.63B-239.57M-203.77M-1.37B14.71M-684.24M-
Capital Expenditure052.71M30.82M26.83M44.42M47.76M124.02M92.49M73.46M56.87M95.77M315.21M379.81M585.54M831.76M651.24M972.67M1.10B1.43B1.23B1.26B1.13B1.28B956.27M638.28M
Free Cash Flow--15.83M25.86M43.77M-730.85K18.34M-44.81M21.27M50.06M22.97M39.46M-57.46M-30.30M-129.58M-489.32M-139.34M-381.27M809.21M648.66M1.14B13.19M1.28B305.35M669.02M1.46B
Dividends Paid-9.69M19.75M19.24M411.51K40.38M14.37M18.97M52.41M10.18M14.11M185.19M270.21M408.18M517.91M783.64M761.46M987.95M435.58M435.58M435.58M435.58M756.28M754.37M668.50M
FCF to OCF--42.91%45.63%62.00%-1.67%27.74%-56.57%18.69%40.53%28.77%29.18%-22.29%-8.67%-28.42%-142.89%-27.22%-64.47%42.40%31.15%48.11%1.04%53.02%19.21%41.16%69.55%
Dividend Paid to FCF--61.22%76.35%43.96%-56.31%220.22%-32.07%89.18%104.69%44.31%35.75%-322.30%-891.65%-315.01%-105.84%-562.39%-199.72%122.09%67.15%38.16%3302.64%34.12%247.67%112.76%45.86%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Nov 30, 2011Feb 29, 2012Apr 24, 2012Aug 6, 2012Oct 27, 2012Feb 27, 2013Jun 7, 2013Aug 28, 2013Oct 28, 2013Feb 26, 2014May 28, 2014Aug 8, 2014Oct 29, 2014Feb 13, 2015Apr 17, 2015Jul 3, 2015Oct 30, 2015Feb 26, 2016Apr 27, 2016Aug 26, 2016Oct 26, 2016Feb 23, 2017Apr 21, 2017Aug 25, 2017Oct 29, 2017Apr 27, 2018Aug 29, 2018Oct 30, 2018Dec 31, 2018Apr 10, 2019Aug 22, 2019Oct 30, 2019Apr 29, 2020Aug 15, 2020Oct 31, 2020Apr 30, 2021Aug 30, 2021Nov 1, 2021Mar 30, 2022Apr 29, 2022Aug 19, 2022Oct 31, 2022Apr 29, 2023Aug 29, 2023Oct 31, 2023May 23, 2024Aug 31, 2024Oct 29, 2024May 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------0.060.080.06-0.04-0.060.04-0.11------0.09--0.020.100.10------------------------------
EPS Actual0.020.030.040.050.020.040.050.200.040.080.070.020.040.070.060.020.050.100.080.040.100.110.100.020.090.120.10-0.020.070.080.060.050.110.080.020.050.100.110.060.120.100.070.120.080.080.090.200.080.090.110.060.080.080.070.090.100.110.050.080.08
Surprise---------33.33%0.00%16.67%-0.00%-0.00%-50.00%--9.09%------0.00%---210.00%-30.00%-20.00%------------------------------
Timing--------After-hoursAfter-hoursPre-market-Pre-market-After-hoursAfter-hours-After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-market---------Pre-market-----After-hours--After-hours-----

Key Statistics & Ratios

Market Cap8.55B
Enterprise Value11.89B
Trailing P/E13.09
Forward P/E20.79
PEG Ratio0.00
Price / Sales0.75
Price / Book0.86
EPS0.33
Book Value5.12
Revenue (TTM)11.48B
Gross Profit (TTM)4.23B
EBITDA2.39B
Profit Margin5.61%
Operating Margin13.29%
Return on Equity5.22%
Return on Assets2.95%
Shares Outstanding1.98B
Shares Float1.28B
Beta0.26
Dividend Yield8.22%
Dividend Rate0.35
Payout Ratio107.20%

Dividends

20261×
0.25Jun 16, 2026
20251×
0.20Sep 16, 2025
20241×
0.22Jun 3, 2024
20231×
0.22Jun 15, 2023
20221×
0.22Jun 2, 2022
20211×
0.22Apr 30, 2021
20201×
0.22Jun 19, 2020
20191×
0.22Jul 5, 2019
20181×
0.20Jun 15, 2018
20171×
0.15Jun 16, 2017
20161×
0.20Jun 30, 2016
20151×
0.12May 27, 2015
20141×
0.12Oct 27, 2014
20131×
0.12Jul 10, 2013
20121×
0.07May 15, 2012
20091×
0.04May 22, 2009
20061×
0.04May 25, 2006
20041×
0.01Oct 18, 2004

Stock Splits

  • May 27, 201525:10
  • Sep 4, 201215:10
  • May 15, 201220:10
  • Nov 3, 200513.3:10
  • Oct 18, 20041.5:1